Cosmo Pharmaceuticals NV
SIX:COPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
IE |
|
C
|
Canadian Imperial Bank of Commerce
NYSE:CM
|
CA |
|
Arafura Resources Ltd
ASX:ARU
|
AU |
|
Svenska Handelsbanken AB
F:SVHH
|
SE |
|
Emerita Resources Corp
XTSX:EMO
|
CA |
|
Pearson PLC
LSE:PSON
|
UK |
|
U
|
Universal Resource and Services Ltd
SGX:BGO
|
SG |
|
Bluejay Mining PLC
LSE:JAY
|
UK |
|
boohoo group plc
LSE:DEBS
|
UK |
|
Spindex Industries Ltd
SGX:564
|
SG |
|
Laureate Education Inc
NASDAQ:LAUR
|
US |
|
Fermentalg SA
PAR:FALG
|
FR |
|
N
|
Nike Inc
XMUN:NKE
|
US |
|
Atlas Copco AB
F:ACO
|
SE |
|
V
|
Vaxil Bio Ltd
OTC:VXLLF
|
CA |
|
Calfrac Well Services Ltd
TSX:CFW
|
CA |
|
Nextech Ar Solutions Corp
OTC:NEXCF
|
CA |
|
Varun Beverages Ltd
NSE:VBL
|
IN |
|
Mirion Technologies Inc
F:55I0
|
US |
|
A
|
Amgen Inc
DUS:AMG
|
US |
|
F
|
Fuelcell Energy Inc
F:FEY2
|
US |
|
W
|
West Fraser Timber Co Ltd
F:WFC
|
CA |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
US |
|
Anglo American Platinum Ltd
F:RPHA
|
ZA |
Dividends
Dividend Yield
Cosmo Pharmaceuticals NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Cosmo Pharmaceuticals NV
COPN have decreased by 0%.
Payout Ratio
Cosmo Pharmaceuticals NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for COPN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
COPN Price
Cosmo Pharmaceuticals NV
| Average Annual Return | -5.65% |
| Standard Deviation of Annual Returns | 16.76% |
| Max Drawdown | -62% |
| Market Capitalization | 1.2B CHF |
| Shares Outstanding | 17 540 000 |
| Percentage of Shares Shorted |
N/A
|
